---
title: Effective reprogramming of patient-derived M2-polarized glioblastoma-associated
  microglia/macrophages by treatment with GW2580
date: '2023-09-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37682326/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230908181252&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: This comparative analysis of CSF1R-targeting drugs on patient-derived
  GAMs and human glioblastoma avatars identified GW2580 as the most powerful inhibitor
  with the ability to polarize immunosuppressive GAMs to a proinflammatory phenotype,
  supporting antitumor T cell responses while also exerting a direct antitumor effect.
  These data indicate that GW2580 could be an important pillar in future therapies
  for ...'
disable_comments: true
---
CONCLUSION: This comparative analysis of CSF1R-targeting drugs on patient-derived GAMs and human glioblastoma avatars identified GW2580 as the most powerful inhibitor with the ability to polarize immunosuppressive GAMs to a proinflammatory phenotype, supporting antitumor T cell responses while also exerting a direct antitumor effect. These data indicate that GW2580 could be an important pillar in future therapies for ...